134 related articles for article (PubMed ID: 9027583)
1. Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5-trisphosphate binding to its receptor.
Misra UK; Gawdi G; Pizzo SV
J Cell Biochem; 1997 Feb; 64(2):225-32. PubMed ID: 9027583
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A inhibits inositol 1,4,5-trisphosphate binding to its receptors and release of calcium from intracellular stores in peritoneal macrophages.
Misra UK; Gawdi G; Pizzo SV
J Immunol; 1998 Dec; 161(11):6122-7. PubMed ID: 9834096
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of truncated inositol 1,4,5-trisphosphate receptor subunits in 3T3 fibroblasts. Coordinate signaling changes and differential suppression of cell growth and transformation.
Fischer GA; Clementi E; Raichman M; Südhof T; Ullrich A; Meldolesi J
J Biol Chem; 1994 Jul; 269(30):19216-24. PubMed ID: 8034682
[TBL] [Abstract][Full Text] [Related]
4. Creation of an inositol 1,4,5-trisphosphate-sensitive Ca2+ store in secretory granules of insulin-producing cells.
Blondel O; Bell GI; Moody M; Miller RJ; Gibbons SJ
J Biol Chem; 1994 Nov; 269(44):27167-70. PubMed ID: 7961623
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of types-1 and -3 inositol trisphosphate receptors by cytosolic Ca2+.
Cardy TJ; Traynor D; Taylor CW
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):785-93. PubMed ID: 9396721
[TBL] [Abstract][Full Text] [Related]
6. Differences among type I, II, and III inositol-1,4,5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1,4,5-trisphosphate.
Wojcikiewicz RJ; Luo SG
Mol Pharmacol; 1998 Apr; 53(4):656-62. PubMed ID: 9547355
[TBL] [Abstract][Full Text] [Related]
7. Luminal calcium regulates the inositol trisphosphate receptor of rat basophilic leukemia cells at a cytosolic site.
Horne JH; Meyer T
Biochemistry; 1995 Oct; 34(39):12738-46. PubMed ID: 7548027
[TBL] [Abstract][Full Text] [Related]
8. Role of inositol 1,4,5-trisphosphate receptor in ventral signaling in Xenopus embryos.
Kume S; Muto A; Inoue T; Suga K; Okano H; Mikoshiba K
Science; 1997 Dec; 278(5345):1940-3. PubMed ID: 9395395
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of inositol-1,4,5,-trisphosphate binding to membranes from retina and retinal cultures.
López-Colomé AM; Lee I
J Neurosci Res; 1996 Apr; 44(2):149-56. PubMed ID: 8723223
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of channel density in inositol-1,4,5-trisphosphate-sensitive Ca2+ stores.
Hirose K; Iino M
Nature; 1994 Dec 22-29; 372(6508):791-4. PubMed ID: 7997268
[TBL] [Abstract][Full Text] [Related]
11. Trypsinized cerebellar inositol 1,4,5-trisphosphate receptor. Structural and functional coupling of cleaved ligand binding and channel domains.
Yoshikawa F; Iwasaki H; Michikawa T; Furuichi T; Mikoshiba K
J Biol Chem; 1999 Jan; 274(1):316-27. PubMed ID: 9867846
[TBL] [Abstract][Full Text] [Related]
12. Quantal Ca2+ release and inactivation in a model of the inositol 1,4,5-trisphosphate receptor involving transformation of the ligand by the receptor.
Kaimachnikov NP; Nazarenko VG
Biosci Rep; 1996 Oct; 16(5):405-13. PubMed ID: 8913530
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic inositol 1,4,5-trisphosphate dynamics during intracellular calcium oscillations in living cells.
Matsu-ura T; Michikawa T; Inoue T; Miyawaki A; Yoshida M; Mikoshiba K
J Cell Biol; 2006 Jun; 173(5):755-65. PubMed ID: 16754959
[TBL] [Abstract][Full Text] [Related]
14. Regulation of inositol 1,4,5-trisphosphate receptors in rat basophilic leukemia cells. II. Modulation of the receptor in permeabilized cells by the cytosolic compartment.
Hershey PE; Pessah IN; Mohr FC
Biochim Biophys Acta; 1993 Apr; 1147(1):115-24. PubMed ID: 8385493
[TBL] [Abstract][Full Text] [Related]
15. The bell-shaped Ca2+ dependence of the inositol 1,4, 5-trisphosphate-induced Ca2+ release is modulated by Ca2+/calmodulin.
Missiaen L; Parys JB; Weidema AF; Sipma H; Vanlingen S; De Smet P; Callewaert G; De Smedt H
J Biol Chem; 1999 May; 274(20):13748-51. PubMed ID: 10318777
[TBL] [Abstract][Full Text] [Related]
16. Adenophostin-medicated quantal Ca2+ release in the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1.
Hirota J; Michikawa T; Miyawaki A; Takahashi M; Tanzawa K; Okura I; Furuichi T; Mikoshiba K
FEBS Lett; 1995 Jul; 368(2):248-52. PubMed ID: 7628615
[TBL] [Abstract][Full Text] [Related]
17. IP3 receptor-operated calcium entry.
Mikoshiba K; Hattori M
Sci STKE; 2000 Sep; 2000(51):pe1. PubMed ID: 11752610
[TBL] [Abstract][Full Text] [Related]
18. Intracellular calcium concentration in the inositol trisphosphate receptor type 1 knockout mouse.
Hayashi M; Monkawa T; Yoshida T; Sasamura H; Matsumoto M; Inoue T; Mikoshiba K; Saruta T
J Am Soc Nephrol; 1999 Oct; 10(10):2094-101. PubMed ID: 10505685
[TBL] [Abstract][Full Text] [Related]
19. Modulation of inositol 1,4,5-trisphosphate binding to the various inositol 1,4,5-trisphosphate receptor isoforms by thimerosal and cyclic ADP-ribose.
Vanlingen S; Sipma H; De Smet P; Callewaert G; Missiaen L; De Smedt H; Parys JB
Biochem Pharmacol; 2001 Apr; 61(7):803-9. PubMed ID: 11274965
[TBL] [Abstract][Full Text] [Related]
20. Control of Ca2+ influx in human neutrophils by inositol 1,4,5-trisphosphate (IP3) binding: differential effects of micro-injected IP3 receptor antagonists.
Davies-Cox EV; Laffafian I; Hallett MB
Biochem J; 2001 Apr; 355(Pt 1):139-43. PubMed ID: 11256958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
